Barnes DM - Search Results

1

Cyclin D1 in mammary carcinoma.

Barnes DM. Barnes DM. J Pathol. 1997 Mar;181(3):267-9. doi: 10.1002/(SICI)1096-9896(199703)181:3<267::AID-PATH783>3.0.CO;2-X. J Pathol. 1997. PMID: 9155710 Review.

2

MSI-low, a real phenomenon which varies in frequency among cancer types.

Halford SE, Sawyer EJ, Lambros MB, Gorman P, Macdonald ND, Talbot IC, Foulkes WD, Gillett CE, Barnes DM, Akslen LA, Lee K, Jacobs IJ, Hanby AM, Ganesan TS, Salvesen HB, Bodmer WF, Tomlinson IP, Roylance RR. Halford SE, et al. Among authors: barnes dm. J Pathol. 2003 Nov;201(3):389-94. doi: 10.1002/path.1453. J Pathol. 2003. PMID: 14595750

3

BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data.

Townsend PA, Dublin E, Hart IR, Kao RH, Hanby AM, Cutress RI, Poulsom R, Ryder K, Barnes DM, Packham G. Townsend PA, et al. Among authors: barnes dm. J Pathol. 2002 May;197(1):51-9. doi: 10.1002/path.1081. J Pathol. 2002. PMID: 12081204

4

p21(WAF1) expression and endocrine response in breast cancer.

McClelland RA, Gee JM, O'Sullivan L, Barnes DM, Robertson JF, Ellis IO, Nicholson RI. McClelland RA, et al. Among authors: barnes dm. J Pathol. 1999 Jun;188(2):126-32. doi: 10.1002/(SICI)1096-9896(199906)188:2<126::AID-PATH340>3.0.CO;2-O. J Pathol. 1999. PMID: 10398154

5

p53 immunohistochemical staining and survival after adjuvant chemotherapy for breast cancer.

Dublin EA, Miles DW, Rubens RD, Smith P, Barnes DM. Dublin EA, et al. Among authors: barnes dm. Int J Cancer. 1997 Dec 19;74(6):605-8. doi: 10.1002/(sici)1097-0215(19971219)74:6<605::aid-ijc8>3.0.co;2-y. Int J Cancer. 1997. PMID: 9421356 Clinical Trial.

6

Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?

Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR. Barnes DM, et al. Hum Pathol. 1993 May;24(5):469-76. doi: 10.1016/0046-8177(93)90158-d. Hum Pathol. 1993. PMID: 7684021

7

Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor.

Cooper LS, Gillett CE, Patel NK, Barnes DM, Fentiman IS. Cooper LS, et al. Among authors: barnes dm. Cancer. 1999 Nov 15;86(10):2053-8. doi: 10.1002/(sici)1097-0142(19991115)86:10<2053::aid-cncr24>3.0.co;2-h. Cancer. 1999. PMID: 10570431

8

Tumour grade does not change between primary and recurrent mammary carcinoma.

Millis RR, Barnes DM, Lampejo OT, Egan MK, Smith P. Millis RR, et al. Among authors: barnes dm. Eur J Cancer. 1998 Mar;34(4):548-53. doi: 10.1016/s0959-8049(97)10072-7. Eur J Cancer. 1998. PMID: 9713307

9

Cell proliferation measured by MIB1 and timing of surgery for breast cancer.

Cooper LS, Gillett CE, Smith P, Fentiman IS, Barnes DM. Cooper LS, et al. Among authors: barnes dm. Br J Cancer. 1998 May;77(9):1502-7. doi: 10.1038/bjc.1998.247. Br J Cancer. 1998. PMID: 9652769 Free PMC article.

10

Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters.

Dublin EA, Patel NK, Gillett CE, Smith P, Peters G, Barnes DM. Dublin EA, et al. Among authors: barnes dm. Int J Cancer. 1998 Feb 20;79(1):71-5. doi: 10.1002/(sici)1097-0215(19980220)79:1<71::aid-ijc14>3.0.co;2-k. Int J Cancer. 1998. PMID: 9495362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results